If made a priority, point-of-care diagnostic kits could be developed within months at a cost of tens of millions of dollars. Several companies are racing to develop one, but they need help to succeed.
Read more: https://hbr.org/2020/02/we-need-a-cheap-way-to-diagnose-coronavirus